DNA SEQUENCING IN DRUG DISCOVERY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-172689 | IT And Telecommunication
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
DNA Sequencing In Drug Discovery Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET
7.1 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DNA SEQUENCING IN DRUG DISCOVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Thermo Fisher Scientific Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Sigma-Aldrich Corporation
16.3 Siemens Healthcare Diagnostics
16.4 Promega Corporation
16.5 Nanogen Inc
16.6 GVK Biosciences Private Limited
16.7 Illumina Inc
16.8 Roche Diagnostics
16.9 Bio-Rad Laboratories Inc
16.10 Beckman Coulter (Danaher Corporation)
16.11 454 Life Sciences
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market segment by Type, the product can be split into- Microarrays
- Polymerase Chain Reaction (pcr) Techniques
Market segment by Application, split into
- Pharmaceutical
- Other
Companies
Thermo Fisher Scientific Inc
Sigma-Aldrich Corporation
Siemens Healthcare Diagnostics
Promega Corporation
Nanogen Inc
GVK Biosciences Private Limited
Illumina Inc
Roche Diagnostics
Bio-Rad Laboratories Inc
Beckman Coulter (Danaher Corporation)
454 Life Sciences
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.